T. Audomsun

Highly efficient hybridoma generation and screening strategy for anti-PD-1 monoclonal antibody development

T. Pisitkun, N. Hirankarn, S. Sooksai, 2022, Scientific Reports.

A randomized, placebo-controlled trial of a nasal spray solution containing broadly potent neutralizing antibodies against SARS-CoV-2 variants in healthy volunteers

P. Opanasopit, P. Saelao, C. Sawangmake, 2022, medRxiv.

Efficacy of the combination of monoclonal antibodies against the SARS-CoV-2 Beta and Delta variants

T. Pisitkun, A. Malik, U. Thisyakorn, 2023, PloS one.